Site-Overview.com
 

Websites using novonordiskpro as a keyword

Here you can see a list of websites which are using novonordiskpro as keyword according to our database.

 
Websites found: 11
Number of websited displayed: 11
 

List of results:

Diabetes Resources & Patient Care for Health Care Professionals | NovoMedLink
http://site-overview.com/stats/novomedlink.com
US health care professionals can get Novo Nordisk product information and videos, product samples, patient education materials and formulary coverage data.
  • Google Analytics ID: 44074826-1
  • Website Address renewal date: 16/2/16
  • Domain Address Reg. date: 03/3/27
  • Website address in use until: 19/3/27
Levemir® (insulin detemir [rDNA origin] injection) HCP Website
http://site-overview.com/stats/levemirpro.com
See information about basal insulin & the long-acting insulin from Levemir®. Read Important Safety & Prescribing Info from the Levemir® HCP Website.
  • Google Analytics ID: 44074826-2
  • Website Address renewal date: 16/11/1
  • Domain Address Reg. date: 10/10/28
  • Website address in use until: 18/10/28
Login
http://site-overview.com/stats/novonordiskpro.jp
  • Website Address renewal date: 16/8/1
  • Domain Address Reg. date: 12/7/5
  • Website address in use until: 17/7/31
Welcome to Novo Nordisk UK- Novo Nordisk A/S
http://site-overview.com/stats/novonordisk.co.uk
Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.
  • Website Address renewal date: 17/2/19
  • Domain Address Reg. date: 97/2/20
  • Website address in use until: 19/2/20
Tresiba® (insulin degludec injection 100 U/mL, 200 U/mL) HCP Website
http://site-overview.com/stats/tresibapro.com
Try our once-daily, long-acting insulin to improve glycemic control in pediatric & adult patients with diabetes. Read Important Safety & Prescribing Info.
  • Google Analytics ID: 44074826-83
  • Website Address renewal date: 17/2/17
  • Domain Address Reg. date: 12/2/14
  • Website address in use until: 19/2/14
Fiasp® Fast-Acting Insulin | Fiasp® (insulin aspart injection) 100 U/mL
http://site-overview.com/stats/fiasppro.com
Fiasp® is a fast-acting insulin aspart indicated to improve glycemic control in adults with type 1 or type 2 diabetes. Read important safety & prescribing info on this page.
  • Known AddThis user account: ra-57d08e7d95e26a45
  • Google Analytics ID: 44074826-94
  • Website Address renewal date: 16/12/20
  • Domain Address Reg. date: 16/12/20
  • Website address in use until: 18/12/20
Rethink Obesity® | HCP Support Website
http://site-overview.com/stats/rethinkobesity.com
Discover the science behind obesity and get tools to support weight management. Visit the HCP support website and learn how obesity may influence your patients.
  • Google Analytics ID: 44074826-6
  • Website Address renewal date: 16/2/16
  • Domain Address Reg. date: 14/2/6
  • Website address in use until: 19/2/6
Xultophy® 100/3.6 (insulin degludec and liraglutide injection) 100 u/mL and 3.6 mg/mL | HCP Website
http://site-overview.com/stats/xultophy10036pro.com
Learn about Xultophy® 100/3.6, basal insulin & GLP-1 in one injection. Read Important Safety Information & Prescribing Information, including Boxed Warning.
  • Google Analytics ID: 44074826-91
  • Website Address renewal date: 16/9/26
  • Domain Address Reg. date: 16/9/26
  • Website address in use until: 18/9/26
Novo Nordisk Mexico
http://site-overview.com/stats/novonordisk.com.mx
  • Google+ Identity: +novonordisk
  • Website Address renewal date: 18/2/27
  • Domain Address Reg. date: 02/9/18
  • Website address in use until: 19/9/17
NovoLog® (insulin aspart injection) 100 U/mL HCP Website
http://site-overview.com/stats/novologpro.com
View the official health care professionals website with clinical trial information and resources on NovoLog®.
  • Google Analytics ID: 44074826-3
  • Website Address renewal date: 16/11/1
  • Domain Address Reg. date: 10/10/28
  • Website address in use until: 18/10/28
GLP-1 RA Therapy for T2D | Ozempic® (semaglutide) injection 0.5 mg or 1 mg
http://site-overview.com/stats/ozempicpro.com
Once weekly Ozempic® for Type 2 diabetes is now available in pharmacies. See Full Prescribing and Safety Information including Boxed Warning.
  • Website Address renewal date: 17/9/22
  • Domain Address Reg. date: 16/10/3
  • Website address in use until: 18/10/3
2024-05-24 17:37:30 ... 0.0092